Industrial Rhamnolipid Market - By Type (Mono-Rhamnolipids, Di-Rhamnolipids), By Form (Liquid, Powder), By End Use Industry (Oil & Gas, Agriculture, Pharmaceuticals & Healthcare, Cosmetics & Personal Care) & Forecast, 2024 – 2032

AGAE Technologies, Biotensidon GmbH, Evonik Industries AG, GlycoSurf, Jeneil Biotech, Shaanxi Deguan Biotechnology Co., Ltd, Stepan Company, and TensioGreen.

Asia Pacific industrial rhamnolipid market acquired over 30% of the share in 2023 and will continue to grow through 2032, bolstered by rapid industrialization and significant investments in sustainable technologies.

Mono-rhamnolipids segment will show a 6.7% growth rate by 2032, owing to their versatile applications and superior performance in processes like enhanced oil recovery and cleaning solutions.

The industrial rhamnolipid industry was valued at USD 410.6 million in 2023 and will record a 7.1% CAGR from 2024 to 2032, due to its increased use in enhanced oil recovery (EOR) in the oil & gas sector and its expanding applications in cosmetics and personal care.